Highlights HemaCare Corporation

Equities

HEMA

US4234981045

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.08%	+0.24%

2020	HemaCare Corporation Adds GMPrime Cryopreserved Leukopak to its GMP Product Portfolio	CI
2020	MicroMedicine and HemaCare Announces Cooperative Efforts to Improve Cell Therapy Starting Materials	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HemaCare Corporation Adds GMPrime Cryopreserved Leukopak to its GMP Product Portfolio	02/06/20	CI
MicroMedicine and HemaCare Announces Cooperative Efforts to Improve Cell Therapy Starting Materials	21/01/20	CI
Charles River Laboratories International, Inc. completed the acquisition of HemaCare Corporation.	02/01/20	CI
Charles River Laboratories International, Inc. entered into a definitive agreement to acquire HemaCare Corporation for approximately $380 million.	15/12/19	CI
HemaCare Expands Its Product Portfolio with GMPrime™ Bone Marrow Aspirate	19/11/19	CI
HemaCare Corporation and Vital River Partner to Provide Human-Derived Biological Material to China	27/08/19	CI
Hemacare Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	20/08/19	CI
HemaCare Corporation Reports Earnings Results for the Year Ended December 31, 2018	26/03/19	CI
HemaCare Corporation Provides Starting Material for Three FDA Approved Cellular Therapies	14/11/18	CI
HemaCare Corporation Reports Unaudited Earnings Results for the Six Months Ended June 30, 2018	21/08/18	CI
HemaCare Corporation Reports Earnings Results for the Full Year Ended December 31, 2017	08/03/18	CI
HemaCare Corporation and Charles River Laboratories International Inc. Announces Strategic Partnership to Accelerate Drug Discovery and Development	06/02/18	CI
HemaCare Corporation Reports Unaudited Earnings Results for the First Six Months Ended June 30, 2017	21/08/17	CI
HemaCare Signs Long Term Lease for Facility Relocation and Expansion	24/07/17	CI
HemaCare Corporation Reports Financial Results for the Year Ended December 31, 2016	13/03/17	CI
HemaCare Corporation Signs Distribution Agreement with Almog Diagnostic	20/02/17	CI
HemaCare Signs Distribution Agreement with Accuresearch Korea, Inc	31/10/16	CI
HemaCare Corp. Reports Unaudited Earnings Results for the First Six Months Ended June 30, 2016	06/09/16	CI
HemaCare Corporation Signs Strategic Distribution Agreement with MT-Biological Science and Technology Co. Ltd	12/05/16	CI
HemaCare Corp. Expands its Offering of Stem Cell-Enriched Peripheral Blood	28/03/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HemaCare Corporation

Equities

HEMA

US4234981045

Highlights

Filters